Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

78 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[68Ga]FAPI-PET/CT for radiation therapy planning in biliary tract, pancreatic ductal adeno-, and adenoidcystic carcinomas.
Guberina N, Kessler L, Pöttgen C, Guberina M, Metzenmacher M, Herrmann K, Mucha M, Rischpler C, Indenkämpen F, Siveke JT, Treckmann J, Umutlu L, Kasper S, Fendler WP, Stuschke M. Guberina N, et al. Among authors: guberina m. Sci Rep. 2022 Sep 28;12(1):16261. doi: 10.1038/s41598-022-20447-6. Sci Rep. 2022. PMID: 36171444 Free PMC article.
Whole-Body Integrated [68Ga]PSMA-11-PET/MR Imaging in Patients with Recurrent Prostate Cancer: Comparison with Whole-Body PET/CT as the Standard of Reference.
Guberina N, Hetkamp P, Ruebben H, Fendler W, Grueneisen J, Suntharalingam S, Kirchner J, Puellen L, Harke N, Radtke JP, Umutlu L, Hadaschik BA, Herrmann K, Forsting M, Wetter A. Guberina N, et al. Mol Imaging Biol. 2020 Jun;22(3):788-796. doi: 10.1007/s11307-019-01424-4. Mol Imaging Biol. 2020. PMID: 31482413
Combined radiotherapy and concurrent tumor treating fields (TTFields) for glioblastoma: Dosimetric consequences on non-coplanar IMRT as initial results from a phase I trial.
Guberina N, Pöttgen C, Kebir S, Lazaridis L, Scharmberg C, Lübcke W, Niessen M, Guberina M, Scheffler B, Jendrossek V, Jabbarli R, Pierscianek D, Sure U, Schmidt T, Oster C, Hau P, Grosu AL, Stuschke M, Glas M, Nour Y, Lüdemann L. Guberina N, et al. Among authors: guberina m. Radiat Oncol. 2020 Apr 19;15(1):83. doi: 10.1186/s13014-020-01521-7. Radiat Oncol. 2020. PMID: 32307022 Free PMC article. Clinical Trial.
Assessment of Suspected Malignancy or Infection in Immunocompromised Patients After Solid Organ Transplantation by [18F]FDG PET/CT and [18F]FDG PET/MRI.
Guberina N, Gäckler A, Grueneisen J, Wetter A, Witzke O, Herrmann K, Rischpler C, Fendler W, Umutlu L, Sawicki LM, Forsting M, Rohn H. Guberina N, et al. Nucl Med Mol Imaging. 2020 Aug;54(4):183-191. doi: 10.1007/s13139-020-00648-5. Epub 2020 Jul 2. Nucl Med Mol Imaging. 2020. PMID: 32831964 Free PMC article.
Estimation of radiation exposure of children undergoing superselective intra-arterial chemotherapy for retinoblastoma treatment: assessment of local diagnostic reference levels as a function of age, sex, and interventional success.
Opitz M, Bos D, Deuschl C, Radbruch A, Zensen S, Sirin S, Forsting M, Bechrakis N, Biewald E, Bornfeld N, Ketteler P, Timmermann B, Stuschke M, Guberina M, Wetter A, Göricke S, Guberina N. Opitz M, et al. Among authors: guberina n, guberina m. Neuroradiology. 2021 Mar;63(3):391-398. doi: 10.1007/s00234-020-02540-7. Epub 2020 Aug 29. Neuroradiology. 2021. PMID: 32862237 Free PMC article.
Comparison of early tumour-associated versus late deaths in patients with central or >7 cm T4 N0/1 M0 non-small-cell lung-cancer undergoing trimodal treatment: Only few risks left to improve.
Guberina N, Pöttgen C, Schuler M, Guberina M, Stamatis G, Plönes T, Krebs B, Metzenmacher M, Theegarten D, Gauler T, Jöckel KH, Darwiche K, Aigner C, Stuschke M, Eberhardt WE. Guberina N, et al. Among authors: guberina m. Eur J Cancer. 2020 Oct;138:156-168. doi: 10.1016/j.ejca.2020.07.025. Epub 2020 Sep 2. Eur J Cancer. 2020. PMID: 32889370
78 results